InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Roberts Brandi. Director active across 3 companies, notably TFF Pharmaceuticals, Inc.. In total, 7 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €5k. History available since 15 August 2023. The latest transaction was disclosed on 12 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Roberts Brandi is a declarant linked to 7 filings in total. In the sampled recent filings from 2023-08-15 to 2026-08-12, the reported buy volume is EUR 4585 and the reported sell volume is EUR 0. The primary role is not provided, but the listed companies are Definium Therapeutics, Inc., where the role is Chief Financial Officer, TFF Pharmaceuticals, Inc., where the role is Director, and Longboard Pharmaceuticals, Inc., where the role is CFO.